Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,643 | 322 | 99.4% |
| Education | $29.99 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,811 | 165 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $651.22 | 45 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $382.33 | 26 | $0 (2024) |
| Corium, LLC | $281.20 | 11 | $0 (2024) |
| ITI, Inc. | $207.75 | 6 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $194.80 | 9 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $120.23 | 5 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $117.08 | 6 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $101.09 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,276 | 91 | ABBVIE INC. ($281.76) |
| 2023 | $1,458 | 79 | ABBVIE INC. ($603.05) |
| 2022 | $549.35 | 44 | ABBVIE INC. ($322.70) |
| 2021 | $1,390 | 109 | AbbVie Inc. ($603.17) |
All Payment Transactions
323 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Central Nervous System | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: Central Nervous System | ||||||
| 11/25/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.51 | General |
| Category: Central Nervous System | ||||||
| 10/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Central Nervous System | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: Central Nervous System | ||||||
| 08/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 143 | $17,400 | $8,235 |
| 2022 | 2 | 50 | 161 | $27,150 | $11,068 |
| 2021 | 3 | 55 | 138 | $24,470 | $9,971 |
| 2020 | 4 | 57 | 154 | $24,820 | $9,165 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 89 | $13,350 | $5,835 | 43.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 18 | 54 | $4,050 | $2,400 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 145 | $25,950 | $10,555 | 40.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 13 | 16 | $1,200 | $513.43 | 42.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 103 | $19,570 | $7,465 | 38.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $3,250 | $1,754 | 54.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 13 | 22 | $1,650 | $752.38 | 45.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 76 | $14,440 | $4,725 | 32.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 14 | 14 | $3,500 | $1,666 | 47.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 34 | $4,630 | $1,459 | 31.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 13 | 30 | $2,250 | $1,315 | 58.4% |
About Kina Crenshaw
Kina Crenshaw is a Psychiatric/Mental Health healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2019. The National Provider Identifier (NPI) number assigned to this provider is 1851941397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kina Crenshaw has received a total of $4,673 in payments from pharmaceutical and medical device companies, with $1,276 received in 2024. These payments were reported across 323 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,643).
As a Medicare-enrolled provider, Crenshaw has provided services to 209 Medicare beneficiaries, totaling 596 services with total Medicare billing of $38,439. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Mobile, AL
- Active Since 09/17/2019
- Last Updated 02/19/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1851941397
Products in Payments
- VRAYLAR (Drug) $1,841
- REXULTI (Drug) $643.01
- CAPLYTA (Drug) $402.55
- Azstarys (Drug) $260.70
- Austedo XR (Drug) $227.48
- VOQUEZNA (Drug) $125.00
- Auvelity (Drug) $120.23
- HETLIOZ (Drug) $117.08
- PERSERIS (Drug) $95.76
- AUSTEDO (Drug) $93.27
- ABILIFY MAINTENA (Drug) $89.68
- SPRAVATO (Drug) $86.66
- SUNOSI (Drug) $85.14
- TRINTELLIX (Drug) $64.75
- ARISTADA (Drug) $63.95
- LATUDA (Drug) $62.81
- UZEDY (Drug) $61.58
- ADHANSIA XR (Drug) $42.33
- APLENZIN (Drug) $25.02
- LYBALVI (Drug) $23.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Mobile
Mr. John Hayes, Crnp, CRNP
Psychiatric/Mental Health — Payments: $29,620
Mary Lee, Crnp, CRNP
Psychiatric/Mental Health — Payments: $9,297
Tammy Lee, Aprn, APRN
Psychiatric/Mental Health — Payments: $8,629
Dolores Bray, Crnp, CRNP
Psychiatric/Mental Health — Payments: $7,722
Robert Willett
Psychiatric/Mental Health — Payments: $7,500
Beverly Ales, Crnp, CRNP
Psychiatric/Mental Health — Payments: $5,293